Page last updated: 2024-09-03

9-o-acetyl-n-acetylneuraminic acid and hydroxychloroquine

9-o-acetyl-n-acetylneuraminic acid has been researched along with hydroxychloroquine in 1 studies

Compound Research Comparison

Studies
(9-o-acetyl-n-acetylneuraminic acid)
Trials
(9-o-acetyl-n-acetylneuraminic acid)
Recent Studies (post-2010)
(9-o-acetyl-n-acetylneuraminic acid)
Studies
(hydroxychloroquine)
Trials
(hydroxychloroquine)
Recent Studies (post-2010) (hydroxychloroquine)
68085,8854744,041

Protein Interaction Comparison

ProteinTaxonomy9-o-acetyl-n-acetylneuraminic acid (IC50)hydroxychloroquine (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)2.951
Alpha-1D adrenergic receptorHomo sapiens (human)4.772
Toll-like receptor 9Homo sapiens (human)0.11
Toll-like receptor 7Homo sapiens (human)3.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Mitrasinovic, PM1

Other Studies

1 other study(ies) available for 9-o-acetyl-n-acetylneuraminic acid and hydroxychloroquine

ArticleYear
Prediction of Single Point Mutations in Human Coronavirus and Their Effects on Binding to 9-O-Acetylated Sialic Acid and Hidroxychloroquine.
    Acta chimica Slovenica, 2020, Volume: 67, Issue:3

    Topics: Binding Sites; Coronavirus Infections; Coronavirus OC43, Human; COVID-19; Humans; Hydroxychloroquine; Molecular Docking Simulation; Point Mutation; Protein Engineering; SARS-CoV-2; Sialic Acids; Spike Glycoprotein, Coronavirus

2020